Table 1 Summary of some key data for age-matched control subjects and the three groups of T2DM patients.

From: Alterations in erythrocyte membrane transporter expression levels in type 2 diabetic patients

 

Individuals in the group (n)

Age (years)

Height (cm)

Weight (kg)

Waist circumference (cm)

BMI (kg/m2)

HbA1c (%)

Control

59

61 ± 12

169 ± 11

77 ± 17

95 ± 13

27 ± 5

5.3 ± 0.5

Untreated

36

64 ± 8

166 ± 12

80 ± 18

99 ± 12

29 ± 5

5.9 ± 0.3

p con/untr

 

0.1723

0.4071

0.3454

0.1989

0.0523

< 0.0001****

Treated

61

63 ± 10

169 ± 10

89 ± 18

109 ± 14

31 ± 5

7 ± 1.2

p con/treat

 

0.3674

0.7583

0.0002***

< 0.0001****

< 0.0001****

< 0.0001****

p untr/treat

 

0.5885

0.2765

0.0215*

0.0004***

0.0756

< 0.0001****

Complication

23

66 ± 9

168 ± 10

87 ± 15

113 ± 10

31 ± 4

8.1 ± 1.3

p con/compl

 

0.0392*

0.7135

0.0128*

< 0.0001****

0.0012**

< 0.0001****

p untr/compl

 

0.3407

0.6851

0.1352

< 0.0001****

0.1773

< 0.0001****

p treat/compl

 

0.1554

0.5343

0.581

0.1644

0.8144

0.0022**

  1. The values are expressed as means ± SD. The p values were calculated by the Welch’s t-test.
Back to article page